期刊文献+

凝血酶活化的富血小板血浆促进人骨髓间充质干细胞增殖 被引量:2

Thrombin-Activated Platelet-Rich Plasma Promotes the Proliferation of Human Marrow Mesenchymal Stem Cells
下载PDF
导出
摘要 目的探索凝血酶活化的富血小板血浆(Thrombin-activated platelet-rich plasma,tPRP)替代牛血清,进行人骨髓间充质干细胞(Mesenchymal stme cells,MSC)分离及培养扩增的可行性。方法分别用MTT法和羧基荧光素二醋酸盐琥珀酰亚胺酯标记细胞技术,观察人骨髓MSC在含有tPRP和胎牛血清培养体系中的增殖状态:利用流式细胞学技术检测细胞表面表型;细胞化学染色法分析不同培养体系所获细胞的成骨及成脂细胞分化能力。结果tPRP培养的人骨髓MSC呈典型的成纤维细胞样形态,且tPRP促MSC增殖能力优于筛选后的胎牛血清。tPRP培养的MSC均表达CD29、CD73、CD166和HLA-ABC,而不表达CD31、CD34、CD45和HLA-DR。体外分化实验显示,利用tPRP培养的MSC具有体外成骨和成脂能力。结论tPRP可以替代胎牛血清,用于人骨髓MSC的培养。 Objective To investigate whether the supernatants of thrombin-activated platelet-rich plasma could be used as a substitute for the isolation and culture-expansion of human mesenchymal stem cells. Methods Human marrow mesenchymal stem cells (MSC) were cultured in media containing the supernatants of thrombin-activated platelet-rich plasma (tPRP) and fecal calf sera (FCS) selected from lots. Their proliferation status was evaluated by MTT and carboxyfluorescence diacetatesuccinimidyl ester-labeling assays. Furthermore, the phenotypic characteristics were analyzed by flow cytometry and the differentiations along adipogenic and osteogenic pathways were assessed by histological staining. Results MSC cultured in medium containing tPRP displayed a typical fibroblast-like morphology and, compared with (FCS), tPRP exhibited more potent activities to support the expansion of MSC. Flow cytometry showed that they were homogenously positive for CD29, CD73, CD166 and HLA-ABC and negative for CD31, CD34, CD45 and HLA-DR. Differentiation assays showed that of MSC cultured with tPRP occupied the capacities of in vitro osteogenesis and adipogenesis. Conclusion It is concluded that human tPRP might be an optional substitute to FCS for MSC proliferation.
出处 《组织工程与重建外科杂志》 2010年第1期14-16,20,共4页 Journal of Tissue Engineering and Reconstructive Surgery
基金 科技重大专项项目(2009zx09503-019) 国家高技术发展项目(863项目)(2007AA02z454) 国家自然科学基金项目(30873018和30971068)
关键词 凝血酶 富血小板血浆 骨髓间充质干细胞 Thrombin Platelet-rich plasma Meoenchymal stem cells
  • 相关文献

参考文献3

二级参考文献15

  • 1郭子宽,王立生,吴祖泽.间充质干细胞在组织再生和免疫调节治疗中的应用[J].中国医药生物技术,2006,1(1):58-61. 被引量:9
  • 2王恒湘,边素艳,陈金龙,汪劲松,郭子宽.间充质干细胞不抑制体内T淋巴细胞的增殖[J].组织工程与重建外科杂志,2006,2(5):248-250. 被引量:6
  • 3吴莹琛,崔磊,曹谊林.组织工程血管研究进展[J].组织工程与重建外科杂志,2006,2(5):288-290. 被引量:3
  • 4张薇薇,郭子宽,李占全.间充质干细胞临床试验中的问题及其解决策略[J].中国实验血液学杂志,2007,15(4):901-904. 被引量:17
  • 5王文栋,张瑾,奚廷斐.骨髓间充质干细胞在骨组织工程中的应用进展[J].组织工程与重建外科杂志,2007,3(4):231-233. 被引量:3
  • 6Ousuke Hayashi,Yoshihiro Katsube,Motohiro Hirose,Hajime Ohgushi,Hiromoto Ito. Comparison of Osteogenic Ability of Rat Mesenchymal Stem Cells from Bone Marrow, Periosteum, and Adipose Tissue[J] 2008,Calcified Tissue International(3):238~247
  • 7Venkata Ramesh Dasari,Daniel G. Spomar,Craig Cady,Meena Gujrati,Jasti S. Rao,Dzung H. Dinh. Mesenchymal Stem Cells from Rat Bone Marrow Downregulate Caspase-3-mediated Apoptotic Pathway After Spinal Cord Injury in Rats[J] 2007,Neurochemical Research(12):2080~2093
  • 8Tobias Birnbaum,Julia Roider,Christoph J. Schankin,Claudio S. Padovan,Christian Schichor,Roland Goldbrunner,Andreas Straube. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines[J] 2007,Journal of Neuro - Oncology(3):241~247
  • 9Hideya Yoshimura,Takeshi Muneta,Akimoto Nimura,Akiko Yokoyama,Hideyuki Koga,Ichiro Sekiya. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle[J] 2007,Cell and Tissue Research(3):449~462
  • 10E. Grube,U. Gerckens,R. Müller,L. Büllesfeld. Drug eluting stents: initial experiences[J] 2002,Zeitschrift für Kardiologie(3):44~48

共引文献25

同被引文献39

  • 1Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999; 284 (5411) : 143 - 147.
  • 2Ball LM, Bemardo ME, Roelofs H, et al. Cotransplaatation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 2007 ; 110 ( 7 ) : 2764 - 2767.
  • 3Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia, 2007 ; 21 ( 8 ) : 1733 - 1738.
  • 4Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem ceils for treatment of steroid-resistant, severe, acute graft-versus-host disease, a ohase II study. Lancet. 2008 : 371 (9624) : 1579 - 1586.
  • 5Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenc- hymal stromal cells. Blood, 2007 ; 110 (10) : 3499 - 3506.
  • 6Dazzi F, Ramasamy R, Glennie S, et al The role of mesenchymal stem cells in haemopoiesis. Blood Rev, 2006 ; 20 (3) : 161 - 171.
  • 7Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002 ; 418(6893) : 41 -49.
  • 8Wilson A, Trumpp A. Bone-marrow hematopoietic-stem-cell niches. Nat Rev lmmunol, 2006; 6(2): 93-106.
  • 9Wynn RF, Hart CA, Corradi-Perini C, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood, 2004; 104(9) : 2643 -2645.
  • 10Muquruma Y, Yahata T, Miyatake H, et al. Reconstitution of the functional human hematopoietic human mesenchymal stem cells in the murine compartment. Blood, 2006; 107 (5): 1878-1887.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部